These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9081332)

  • 1. [Predictive biological factors of response to radiotherapy and chemotherapy in carcinoma of the upper respiratory and digestive tracts].
    Bourhis J; Janot F; Domenge C; Girinski T; Lartigau E; Guichard M; Eschwège F
    Bull Cancer Radiother; 1996; 83(4):308-13. PubMed ID: 9081332
    [No Abstract]   [Full Text] [Related]  

  • 2. Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance.
    Kim SH; Lee SY; Park HR; Sung JM; Park AR; Kang S; Kim BG; Choi YP; Kim YB; Cho NH
    Cancer; 2011 May; 117(9):1864-73. PubMed ID: 21509763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.
    Koukourakis MI; Giatromanolaki A; Fountzilas G; Sivridis E; Gatter KC; Harris AL
    Clin Cancer Res; 2000 Feb; 6(2):381-9. PubMed ID: 10690514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy plus chemotherapy for head and neck cancer.
    Michalski J; Emami B
    N Engl J Med; 1993 Feb; 328(8):580. PubMed ID: 8426629
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck.
    Hanna E; Shrieve DC; Ratanatharathorn V; Xia X; Breau R; Suen J; Li S
    Cancer Res; 2001 Mar; 61(6):2376-80. PubMed ID: 11289099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dynamics of plasma transforming growth factor beta 1 (TGF-beta1) level during radiotherapy with or without simultaneous chemotherapy in advanced head and neck cancer.
    Feltl D; Zavadova E; Pala M; Hozak P
    Oral Oncol; 2005 Feb; 41(2):208-13. PubMed ID: 15695123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy.
    Buffa FM; Bentzen SM; Daley FM; Dische S; Saunders MI; Richman PI; Wilson GD
    Clin Cancer Res; 2004 Jun; 10(11):3745-54. PubMed ID: 15173081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predictive of local disease control after intra-arterial concomitant chemoradiation (RADPLAT).
    Robbins KT; Doweck I; Samant S; Vieira F; Kumar P
    Laryngoscope; 2004 Mar; 114(3):411-7. PubMed ID: 15091211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significance.
    Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2301-7. PubMed ID: 9815628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
    McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
    Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
    Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
    Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Concomitant radiotherapy and chemotherapy in the treatment of cancers of the upper respiratory and digestive tracts].
    Calais G; Le Floch O
    Bull Cancer Radiother; 1996; 83(4):321-9. PubMed ID: 9081334
    [No Abstract]   [Full Text] [Related]  

  • 15. Chromosome changes characterizing in vitro response to radiation in human squamous cell carcinoma lines.
    Cowan JM; Beckett MA; Weichselbaum RR
    Cancer Res; 1993 Nov; 53(22):5542-7. PubMed ID: 8221696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
    Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
    Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.
    Roman E; Raez LE; Santos ES
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1205-15. PubMed ID: 17020455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.
    Bradford CR; Zhu S; Ogawa H; Ogawa T; Ubell M; Narayan A; Johnson G; Wolf GT; Fisher SG; Carey TE
    Head Neck; 2003 Aug; 25(8):654-61. PubMed ID: 12884349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy.
    Pirollo KF; Hao Z; Rait A; Jang YJ; Fee WE; Ryan P; Chiang Y; Chang EH
    Oncogene; 1997 Apr; 14(14):1735-46. PubMed ID: 9135075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H; Tsukuda M; Taguchi T
    Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.